IN2009CN03566A - - Google Patents

Download PDF

Info

Publication number
IN2009CN03566A
IN2009CN03566A IN3566CHN2009A IN2009CN03566A IN 2009CN03566 A IN2009CN03566 A IN 2009CN03566A IN 3566CHN2009 A IN3566CHN2009 A IN 3566CHN2009A IN 2009CN03566 A IN2009CN03566 A IN 2009CN03566A
Authority
IN
India
Prior art keywords
compounds
methods
preparing
relates
bompositions
Prior art date
Application number
Other languages
English (en)
Inventor
Josephus H M Lange
Cornelis G Kruse
Belal Shadid
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Priority claimed from PCT/EP2007/064169 external-priority patent/WO2008074816A1/en
Publication of IN2009CN03566A publication Critical patent/IN2009CN03566A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN3566CHN2009 2006-12-20 2007-12-19 IN2009CN03566A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06126584 2006-12-20
PCT/EP2007/064169 WO2008074816A1 (en) 2006-12-20 2007-12-19 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition

Publications (1)

Publication Number Publication Date
IN2009CN03566A true IN2009CN03566A (pt) 2015-08-07

Family

ID=38024247

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3566CHN2009 IN2009CN03566A (pt) 2006-12-20 2007-12-19

Country Status (7)

Country Link
CN (1) CN101848907A (pt)
AR (1) AR064379A1 (pt)
BR (1) BRPI0721060A2 (pt)
IN (1) IN2009CN03566A (pt)
MX (1) MX2009006889A (pt)
TW (1) TW200843772A (pt)
ZA (1) ZA200903779B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102802332B1 (ko) * 2020-07-14 2025-05-07 주식회사 리스큐어바이오사이언시스 페디오코쿠스 이노피나투스 또는 이로부터 유래된 세포밖 소포체를 유효성분으로 포함하는 뇌질환의 치료용 조성물
CN113880899B (zh) * 2020-10-30 2023-06-23 杭州拉林智能科技有限公司 黄酮苷-有机胺类神经激动剂复盐化合物及其制备方法和应用

Also Published As

Publication number Publication date
ZA200903779B (en) 2010-04-28
MX2009006889A (es) 2009-07-07
CN101848907A (zh) 2010-09-29
TW200843772A (en) 2008-11-16
AR064379A1 (es) 2009-04-01
BRPI0721060A2 (pt) 2014-02-25

Similar Documents

Publication Publication Date Title
IL198926A0 (en) Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition
UA94660C2 (en) Amino-heterocyclic compounds
TN2013000285A1 (en) Novel heterocyclic derivatives and their use in the treatment of neurological disorders
MY140693A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
PT1586319E (pt) Inibidores de gsk-3
CU20110106A7 (es) Nuevos compuestos 578
ATE455763T1 (de) Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit
NO20073300L (no) Glycintransportinhibitorer
TW200635903A (en) Therapeutic agents
UA101393C2 (ru) КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ПРОИЗВОДНЫХ ТРИАЗОЛА ДЛЯ ЛЕЧЕНИЯ β-АМИЛОИДОЗОВ И СИНУКЛЕИНОПАТИЙ
TW200630374A (en) Thiazolyldihydroindazoles
MX2009005509A (es) 2-aminoquinolina como los antagonistas de los receptores 5-hidroxitriptamina 5a (5-ht5a).
WO2010018213A3 (en) Spiroimidazole compounds suitable for the treatment of neurological disorders
UA100232C2 (uk) Кристалічні форми інгібітора glyt1
TW200633986A (en) Therapeutic agents
MX2009007405A (es) Compuestos con una combinacion de antagonismo de cb1 cannabinoide e inhibicion de recaptacion de serotonina.
GB0428232D0 (en) Compounds
WO2008102888A1 (ja) 新規擬似糖脂質及びその用途
MX2009006889A (es) Compuestos con una combinacion de antagonismo de cannabinoide-receptor cannabinoide subtipo 1 e inhibicion de acetilcolinesterasa.
WO2008092877A3 (en) 8-oxa-1, 4-diazaspiro [4,5] dec-3-en-1-yl and 1,4, 8-triazaspiro [4,5] dec- 3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
TW200602297A (en) Sulfonamide compounds for the treatment of neurodegenerative disorders
TW200714282A (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
SI1745010T1 (sl) Substituirani cikloheksil-1,4-diaminski derivati
WO2005095348A3 (en) Pyrazole-amine compounds for the treatment of neurodegenerative disorders
MX2010008239A (es) 2-aminoquinolinas.